1Greenbreg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for rracular edama due to central retinal vein occlusion. BR J Opthalmol,2002,86:247-248
2Simon D.M.Chen, Venki S, Jonothan L ,et al. Intravitreal Triamcinolone for the treatment of ischemic macular edema associated with Branch retinal vein occlusion. Am J Opthalmol,2006,141:876-883
3Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triaocular proliferation with intravitreal injection of triamcinilone acetonide. Am J ophthalmol,1980,90:810-816
4Antonetti DA, Wolpert EB, Demaio L, et al. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and deereased phosphorylation od occluding. J Neurochem, 2002,80:667-667
5Young S, Larkin G, Branley M, et al. Safety and efficacy of intravitreal triamcinolone for cysoid macular oedema in uveitis. Clin Experiment ophthalmol, 2001,29:2-6
6Fredorick T, Fraunfelder E Hamptor Roy ed. Current ocular therapy 1990 W.B. saunders company, philadelphia, p669
8Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refraectory diabetic macular ederma.Ophthalmology, 2002,109:920-927
9park CH, Jaffe GL, Fekrats. Intravitreal triam edema associated with central retinal vein occlusion. Am J Ophthalmol, 2003,136:419-425
10Sarema s, Rajasingh J, Biswas Set al. Cellular immune response to retinal S-antigen and interphotoreceptor retinoid-blinding protein fragments in eales disease patients. Pathobiology, 1999,67:39-44
